Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

C R Bard Inc (NYSE:BCR)

253.07
Delayed Data
As of Apr 21
 -1.70 / -0.67%
Today’s Change
203.63
Today|||52-Week Range
255.47
+12.65%
Year-to-Date
BCR Regular Dividend: BCR will begin trading ex-dividend on 04/27/17 with a $0.26 dividend payable to shareholders of record as of 05/01/17.
BD to Buy Bard for $24 Billion
Apr 23 / TheStreet.com - Paid Partner Content
Yacktman Fund Sells Viacom, Oracle, Microsoft
Apr 18 / GuruFocus News - Paid Partner Content
Is a Surprise in Store for C.R. Bard (BCR) in Q1 Earnings?
Apr 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close254.77
Today’s open254.47
Day’s range252.58 - 255.47
Volume413,824
Average volume (3 months)526,484
Market cap$18.3B
Dividend yield0.41%
Data as of 04/21/2017

Growth & Valuation

Earnings growth (last year)+297.18%
Earnings growth (this year)+13.24%
Earnings growth (next 5 years)+10.32%
Revenue growth (last year)+8.72%
P/E ratio36.0
Price/Sales4.55
Price/Book11.01

Competitors

 Today’s
change
Today’s
% change
ZBHZimmer Biomet Holdin...-0.66-0.54%
TFXTeleflex Inc-0.07-0.04%
DXCMDexCom Inc-0.67-0.88%
WSTWest Pharmaceutical ...+0.03+0.04%
Data as of 04/21/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$2.65
Annual revenue (last year)$3.7B
Annual profit (last year)$528.8M
Net profit margin14.24%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Timothy M. Ring
President, Chief Operating Officer &
Director
John H. Weiland
Corporate headquarters
Murray Hill, New Jersey

Forecasts


Search for Jobs